This is an interesting continuing saga from these two companies. Even more reason why transparency in the cardiovascular device space is needed beyond the two industry channel controllers beating each other up. Industry leaders are taking note of these types of articles and recent healthcare trends are coming together to force change and action
"St. Jude Medical Inc. is waging a public relations campaign to protect it's line of implantable heart devices by claiming that more patient deaths are associated with rival products marketed by Medtronic Inc.
On Tuesday, St. Jude lost one round of the battle when the editor of a medical journal said he planned to proceed with print publication of an article released online last month that linked of its products to patients' death. The company, in a press release last month, said it was "seeking a retraction" of the article claiming that it significantly undercounted deaths involving Medtronic devices"
Read the Rest of this article by Christopher Weaver & Anjali Athavely at The Wall Street Journal